OmniBuds Hearables Project by Nokia Bell Labs Backed by Cambridge Future Tech

OmniBuds are the world's first hearables designed to continuously monitor all 5 vital signs, complemented by state-of-the-art augmented hearing capabilities. Conceived by Nokia Bell Labs in Cambridge, UK, the OmniBuds project is now receiving further support from venture builder Cambridge Future Tech. The company entered into a relationship with Nokia Bell Labs and Nokia Ventures & Partnerships to establish OmniBuds Ltd for the commercialization of the OmniBuds platform, as a fully featured ear-worn AI/ML computing platform.

Sonical launched its CosmOS Certified program — an initiative set to drive the hearables market to the next stage of user defined devices. As a pioneering force behind the industry first dedicated operating system for hearables, Sonical wants to foster an ecosystem for customizable and personalized audio and health products. CosmOS Certified validates the software and hardware that makes that vision possible.

Ceva, a leading licensor of silicon and software IP that enables edge devices to connect, sense and infer data more reliably and efficiently, announced that it has extended its Ceva-NeuPro family of NPUs. These meet growing demand for efficient and specialized AI applications at the Edge, where power and processing power is often limited, particularly in consumer products such as TWS earbuds, wearables, smart speakers, smart appliances, home automation devices, cameras, and more.

Sonical, the company pioneering a fully integrated approach for the product development of headphones and hearables, with a real-time operating system that allows consumers to load their own apps has confirmed a development partnership with Sigma Connectivity, the leading Swedish technology design and engineering house. Sigma will help Sonical accelerate the market transition to Headphone 3.0 and the adoption of user driven wearable audio devices.

MindMics, a health technology startup from Cambridge, MA, announced the issuance of its latest patent, US11844618B2, titled "System and Method for Cardiovascular Monitoring and Reporting." This patent marks a significant leap in the field of cardiovascular health, offering a novel, non-invasive approach to disease monitoring and management using standard true wireless earbuds.